Table: Phoenixbio -6-MTH group results
Nov 14 (Reuters)-
Phoenixbio Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 557 mln 1.27
(+4.7 pct)
Operating 26 mln 203 mln
(+6.8 pct)
Recurring loss 29 mln 180 mln
(+20.9 pct)
Net loss 33 mln 155 mln
(+24.2 pct)
EPS loss 11.58 yen 53.86 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Phoenixbio Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T
((Tokyo Headline News Desk +813 6441 1812))